Related references
Note: Only part of the references are listed.Screening of six UGT enzyme activities in human liver microsomes using liquid chromatography/triple quadrupole mass spectrometry
Jeongmin Joo et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2014)
In Vitro Assay of Six UDP-Glucuronosyltransferase Isoforms in Human Liver Microsomes, Using Cocktails of Probe Substrates and Liquid Chromatography-Tandem Mass Spectrometry
Kyung-Ah Seo et al.
DRUG METABOLISM AND DISPOSITION (2014)
Simultaneous determination of morniflumate and its major active metabolite, niflumic acid, in human plasma by high-performance liquid chromatography in stability and pharmacokinetic studies
Hea-Young Cho et al.
BIOMEDICAL CHROMATOGRAPHY (2013)
Effects of rifampin and mefenamic acid on the pharmacokinetics and pharmacodynamics of dapagliflozin
S. Kasichayanula et al.
DIABETES OBESITY & METABOLISM (2013)
Sensitive and Selective Determination of Diflunisal in Human Plasma by LC-MS
Dinesh S. Patel et al.
JOURNAL OF CHROMATOGRAPHIC SCIENCE (2013)
Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry
Anne-Laure Gagez et al.
ANALYTICAL BIOCHEMISTRY (2012)
A high performance liquid chromatography-tandem mass spectrometric method for the determination of mefenamic acid in human plasma: application to pharmacokinetic study
Mahadeo Mahadik et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
Characterization of Niflumic Acid as a Selective Inhibitor of Human Liver Microsomal UDP-Glucuronosyltransferase 1A9: Application to the Reaction Phenotyping of Acetaminophen Glucuronidation
John O. Miners et al.
DRUG METABOLISM AND DISPOSITION (2011)
Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: Inhibition by NSAIDs
Kathleen M. Knights et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Species differences in inhibition potential of nonsteroidal anti-inflammatory drugs against estradiol 3β-glucuronidation between rats, dogs, and humans
Yuji Mano et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2008)
Effect of the β-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases
Lauren Oleson et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2008)
Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver
Yuji Mano et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes
Yuji Mano et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Determination of degradation pathways and kinetics of acyl glucuronides by NMR spectroscopy
Gregory S. Walker et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2007)
In vitro drug interaction between diflunisal and indomethacin via glucuronidation in humans
Yuji Mano et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2006)
In vitro inhibitory effects of non-steroidal anti-inflammatory drugs on 4-methylumbelliferone glucuronidation in recombinant human UDP-glucuronosyltransferase 1A9-potent inhibition by niflumic acid
Y Mano et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2006)
Glucuronidation of nonsteroidal anti-inflammatory drugs: Identifying the enzymes responsible in human liver microsomes
GE Kuehl et al.
DRUG METABOLISM AND DISPOSITION (2005)
Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay
A Di Marco et al.
DRUG METABOLISM AND DISPOSITION (2005)
UDP-glucuronosyltransferases and clinical drug-drug interactions
TKL Kiang et al.
PHARMACOLOGY & THERAPEUTICS (2005)
In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3 beta-glucuronidation in human liver microsomes
Y Mano et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2005)
Simultaneous determination of niflumic acid and its prodrug, talniflumate in human plasma by high performance liquid chromatography
DJ Jang et al.
BIOMEDICAL CHROMATOGRAPHY (2005)
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism
N Picard et al.
DRUG METABOLISM AND DISPOSITION (2005)
Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid
V Uchaipichat et al.
DRUG METABOLISM AND DISPOSITION (2004)
Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6
S Krishnaswamy et al.
DRUG METABOLISM AND DISPOSITION (2004)
Drug-drug interactions for UDP-glucuronosyltransferase substrates:: A pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios
JA Williams et al.
DRUG METABOLISM AND DISPOSITION (2004)
Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin
N Hanioka et al.
XENOBIOTICA (2001)
Characterization of rat and human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of diclofenac
C King et al.
TOXICOLOGICAL SCIENCES (2001)
Share Paper
